A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

Conditions:   Atopic Dermatitis;   Eczema Interventions:   Drug: Bermekimab Monoclonal Antibody;   Drug: Placebo Sponsor:   XBiotech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials